Exelixis, Inc. at its Annual Meeting of Shareholders of 2023, approved election to the Board of Directors of Farallon Capital Management, L.L.C. director candidate: Dave Johnson.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.5 USD | +0.79% | -2.38% | -14.55% |
20/05 | Exelixis Settles Cabometyx Patent Litigation with Cipla | MT |
14/05 | Transcript : Exelixis, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:35 PM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.55% | 592.49Cr | |
+8.38% | 12TCr | |
+10.13% | 10TCr | |
-11.69% | 2.27TCr | |
+2.21% | 2.18TCr | |
-10.88% | 1.82TCr | |
-41.90% | 1.65TCr | |
-16.00% | 1.6TCr | |
+2.28% | 1.41TCr | |
+20.54% | 1.07TCr |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Exelixis, Inc. Elects Dave Johnson to its Board of Directors